Agilent Technologies, Inc.
MHC MULTIMERS IN TUBERCULOSIS DIAGNOSTICS, VACCINE AND THERAPEUTICS
Last updated:
Abstract:
The present invention relates to MHC peptide complexes and uses thereof in the diagnosis of, treatment of or vaccination against a disease in an individual. More specifically the invention discloses MHC complexes comprising Mycobacterium tuberculosis antigenic peptides and uses thereof.
Status:
Application
Type:
Utility
Filling date:
13 Feb 2020
Issue date:
5 Nov 2020